Hunan Haili Chemical Industry Co., Ltd. (600731.SS)
CNY 6.08
(-0.82%)
CNY 6.08
(-0.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.37 Billion | 3.13 Billion | 2.7 Billion | 2.02 Billion | 2.14 Billion | 1.62 Billion |
| Cost of Revenue | 1.84 Billion | 2.34 Billion | 2.08 Billion | 1.4 Billion | 1.56 Billion | 1.23 Billion |
| Gross Profit | 530.13 Million | 786.69 Million | 615.24 Million | 624.9 Million | 580.16 Million | 394.67 Million |
| Operating Expenses | 247.36 Million | 344.04 Million | 265.59 Million | 233.48 Million | 276.65 Million | 208.76 Million |
| Selling, General and Administrative Expenses | 62.54 Million | 64.59 Million | 56.91 Million | 70.15 Million | 101.17 Million | 84.27 Million |
| Research and Development Expenses | 122.16 Million | 145.94 Million | 102.35 Million | 70.44 Million | 86.8 Million | 44.38 Million |
| Other Expenses | -9.9 Million | 133.5 Million | 106.32 Million | 92.88 Million | 88.67 Million | -16.38 Million |
| Cost and Expenses | 2.08 Billion | 2.68 Billion | 2.35 Billion | 1.63 Billion | 1.84 Billion | 1.44 Billion |
| Operating Income | 292.66 Million | 427.96 Million | 325.91 Million | 343.07 Million | 297.68 Million | 123.31 Million |
| Interest Expense | 12.42 Million | 16.42 Million | 15.66 Million | 19.18 Million | 26.13 Million | 22.26 Million |
| Income Tax Expense | 20.63 Million | 53.48 Million | 41.15 Million | 55.05 Million | 47.54 Million | 29.21 Million |
| Earnings before Tax | 304.56 Million | 427.94 Million | 330.27 Million | 355.7 Million | 158.21 Million | 106.93 Million |
| Net Income | 273.77 Million | 352.26 Million | 266.67 Million | 296.39 Million | 101.08 Million | 51.49 Million |
| Earnings Per Share Basic | 0.50 | 0.76 | 0.58 | 0.64 | 0.22 | 0.11 |
| Earnings Per Share Diluted | 0.49 | 0.76 | 0.58 | 0.64 | 0.22 | 0.11 |
| Weighted Average Shares Outstanding | 550.63 Million | 461.78 Million | 461.78 Million | 461.78 Million | 461.78 Million | 453.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 558.74 Million | 461.78 Million | 461.78 Million | 461.78 Million | 461.78 Million | 453.18 Million |
| Gross Margin | 0.22 | 0.25 | 0.23 | 0.31 | 0.27 | 0.24 |
| EBIT Margin | 0.17 | 0.17 | 0.16 | 0.22 | 0.22 | 0.14 |
| Profit Margin | 0.12 | 0.11 | 0.10 | 0.15 | 0.05 | 0.03 |
| EBITDA | 408.4 Million | 528.06 Million | 403.79 Million | 437.45 Million | 244.72 Million | 188.56 Million |
| Earnings Before Tax Margin | 0.12 | 0.14 | 0.12 | 0.17 | 0.14 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 666.69 Million | 693.82 Million | 340.65 Million | 2.37 Billion | 662.89 Million | 477.9 Million |
| Cost of Revenue | 469.8 Million | 553.36 Million | 270.11 Million | 1.83 Billion | 520.43 Million | 409.63 Million |
| Gross Profit | 196.88 Million | 140.45 Million | 70.53 Million | 540.03 Million | 142.46 Million | 68.26 Million |
| Operating Expenses | 90.07 Million | 55.42 Million | 61.77 Million | 308.14 Million | 106.17 Million | 57.68 Million |
| Selling, General and Administrative Expenses | 99.91 Million | 38.7 Million | 35.28 Million | - | -51.1 Million | 83.9 Million |
| Research and Development Expenses | 51.91 Million | 20.76 Million | 26.49 Million | - | 35.82 Million | 19.25 Million |
| Other Expenses | -61.75 Million | 4.03 Million | -145.01 Thousand | 11.89 Million | 8.23 Million | 2.08 Million |
| Cost and Expenses | 559.88 Million | 608.79 Million | 331.89 Million | 2.14 Billion | 626.61 Million | 467.32 Million |
| Operating Income | 107.15 Million | 85.03 Million | 8.76 Million | 292.66 Million | 24.01 Million | 81.76 Million |
| Interest Expense | 1.63 Million | 3.33 Million | 1.57 Million | 11.95 Million | - | - |
| Income Tax Expense | 9.18 Million | 10.92 Million | 5.71 Million | 20.63 Million | -7.3 Million | 4.78 Million |
| Earnings before Tax | 109.94 Million | 105.02 Million | 13.9 Million | 304.56 Million | 32.24 Million | 83.85 Million |
| Net Income | 99.48 Million | 91.45 Million | 9.69 Million | 273.77 Million | 29.39 Million | 81.28 Million |
| Earnings Per Share Basic | 0.18 | 0.16 | 0.02 | - | 0.05 | 0.15 |
| Earnings Per Share Diluted | 0.18 | 0.16 | 0.02 | - | 0.05 | 0.15 |
| Weighted Average Shares Outstanding | 558.74 Million | 558.74 Million | 558.74 Million | 558.74 Million | 558.74 Million | 558.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 558.74 Million | 558.74 Million | 558.74 Million | 558.74 Million | 558.74 Million | 558.74 Million |
| Gross Margin | 0.30 | 0.20 | 0.21 | 0.23 | 0.21 | 0.14 |
| EBIT Margin | 0.17 | 0.16 | 0.05 | - | 0.20 | -0.14 |
| Profit Margin | 0.15 | 0.13 | 0.03 | 0.12 | 0.04 | 0.17 |
| EBITDA | 111.57 Million | 111.03 Million | 16.23 Million | - | 135.8 Million | -66.48 Million |
| Earnings Before Tax Margin | 0.16 | 0.12 | 0.03 | 0.12 | 0.04 | 0.17 |
RIDDHICORP
SGD
3349
EM
LAVV3
MEDS